LDS/Medical Tests/Chlamydia trachomatis and Neisseria gonorrhoeae NA, Liquid Cytology

Chlamydia trachomatis and Neisseria gonorrhoeae NA, Liquid Cytology

Chlamydia trachomatis and Neisseria gonorrhoeae are the most commonly acquired sexually transmitted diseases, or STDs, worldwide. Chlamydia trachomatis, also known as just chlamydia, is the most commonly reported notifiable disease in the US. In 2006, there were over 980,000 cases of chlamydia STDs reported to the CDC. This is almost three times the number of reported gonorrhea infections. Neisseria gonorrhoeae, also called gonorrhea or GC, is the second most commonly reported notifiable STD with over 340,000 cases reported. One reason that chlamydia is more prevalent than GC is that women often have symptoms that are too mild or nonspecific for them to seek medical treatment. This results in chlamydia being 3 times more prevalent in women than men.

Transmission of both chlamydia and gonorrhea are typically by direct contact with infected secretions, usually from sexual contact; however, transmission from mother to child may occur through vaginal delivery, or to other family members through poor hygiene. Commonly infected sites are genitalia, the eyes, throat, and rectum. Both chlamydia and gonorrhea cause disease with symptoms that range from absent to moderate. Once infected, approximately 85% of individuals experience no or relatively mild symptoms. If symptoms are noticeable, they are more common in males than in females and typically present as a light discharge or pain upon urination. If left untreated, both pathogens can result in permanent damage to the reproductive organs leading to infertility in both males and females. Untreated disease can lead to serious complications including pelvic inflammatory disease and infertility in women. Infection during pregnancy can lead to premature births, ectopic pregnancies, infant conjunctivitis, and pneumonia, as well as maternal postpartum endometritis. Among men, urethritis, prostatitis, epididymitis, and infertility are the most common illnesses. The pathogens directly damage the infected cells, but damage also occurs as a result of inflammation, a response of the host-immune system. Neither chlamydia nor gonorrhea infections have a strong or long-lasting immune response, therefore, infection does not protect against reinfection.

The U.S. Preventive Services Task Force recommends routine screening for C. trachomatis and N. gonorrhoeae in sexually active women >25 years of age, all pregnant women, and others at increased risk of infection. Culture testing of these organisms has been mostly replaced with newer molecular methods, which are less prone to sampling errors and are more sensitive and specific. Since the organisms are often transmitted together and present with similar symptoms, they are typically combined into a single assay. Specimen types include vaginal, endocervical, and urethral swabs, urine, and cytology media.

  • Screening for Chlamydia trachomatis infections such as cervicitis, pelvic inflammatory disease (PID), urethritis, and epididymitis
  • As an aid in diagnosis of trachoma, conjunctivitis, pneumonia
  • Screening for Neisseria gonorrhoeae infection in cervicitis, pelvic inflammatory disease, urethritis, epididymitis, and infertility
  • Useful in confirmation for diagnosis of Chlamydia trachomatis and/or Neisseria gonorrhoeae infections

Positive (Detected):

  • Chlamydia trachomatis and/or Neisseria gonorrhoeae infection

Negative (Not Detected)
 

 

Transcription Mediated Amplification (TMA) technology, Polymerase Chain Reaction (PCR), Strain Displacement Amplification.

ThinPrep™ Solution or Digene STM, urine, culture swabs in M4 transport medium, eSwab (universal transport medium). Specimens are stable at room temperature.

C. trachomatis and N. gonorrhoeae culture if indicated, Pap smear, Human Papilloma Virus by molecular method, Herpes simplex virus by PCR or culture, Ureaplasma urealyticum, Mycoplasma homini, Trichomonas vaginalis, Yeast culture, Genital culture for other vaginosis and vaginitis.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login